DrugPatentWatch Database Preview
KEVEYIS Drug Profile
or, see our see our flat-rate plans
Which patents cover Keveyis, and what generic alternatives are available?
The generic ingredient in KEVEYIS is dichlorphenamide. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dichlorphenamide profile page.
Summary for KEVEYIS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 60 |
| Patent Applications: | 1,997 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | KEVEYIS at DailyMed |
Pharmacology for KEVEYIS
| Ingredient-type | Sulfonamides |
| Drug Class | Carbonic Anhydrase Inhibitor |
| Mechanism of Action | Carbonic Anhydrase Inhibitors |
Medical Subject Heading (MeSH) Categories for KEVEYIS
Synonyms for KEVEYIS
| 1,3-Benzenedisulfonamide, 4,5-dichloro- |
| 1,3-Disulfamoyl-4,5-dichlorobenzene |
| 1,3-Disulfamyl-4,5-dichlorobenzene |
| 120-97-8 |
| 120-97-8,76382-13-3(disodiumsalt) |
| 120D978 |
| 2pou |
| 3,4-Dichloro-5-sulfamylbenzenesulfonamide |
| 4,5-Dichloro-1,3-benzenedisulfonamide |
| 4,5-Dichloro-1,3-benzenedisulfonamide # |
| 4,5-Dichloro-1,3-disulfamoylbenzene |
| 4,5-dichloro-3-benzenedisulfonamide |
| 4,5-Dichloro-benzene-1,3-disulfonic acid diamide |
| 4,5-Dichloro-m-benzendisulfonamide |
| 4,5-Dichloro-m-benzenedisulfonamide |
| 4,5-dichlorobenzene-1,3-disulfonamide |
| 4,5-Dicholorobenzene-1,3-disulfonamide |
| A21072 |
| AB0108325 |
| AB2000539 |
| AC-25007 |
| AC1L1F18 |
| AK307798 |
| AKOS015899860 |
| AN-43370 |
| Antidrasi |
| API0002217 |
| Barastonin |
| BC221062 |
| BDBM10883 |
| BPBio1_000745 |
| BRD-K71499074-001-03-8 |
| BRN 2703329 |
| BSPBio_000677 |
| C07459 |
| C6H6Cl2N2O4S2 |
| CAS-120-97-8 |
| CB 8000 |
| CCG-220809 |
| CHEBI:101085 |
| CHEMBL17 |
| CS-2491 |
| CTK6G6454 |
| D00518 |
| D0J4GO |
| D0R0QE |
| Daranide |
| Daranide (TN) |
| Dasanide |
| DB01144 |
| Dichlofenamide |
| Dichlorophenamide |
| Dichlorophenamide (DCP) |
| Dichlorophenamide, DCP |
| Dichlorphenamid |
| dichlorphenamide |
| Dichlorphenamide (Diclofenamide) |
| Dichlorphenamide (USP) |
| Dichlorphenamide [BAN] |
| Dichlorphenamide, United States Pharmacopeia (USP) Reference Standard |
| Dichlorphenamide(Diclofenamide) |
| Diclofenamid |
| Diclofenamida |
| Diclofenamida [INN-Spanish] |
| Diclofenamide |
| Diclofenamide (JP15/INN) |
| Diclofenamide (JP17/INN) |
| Diclofenamide; 4,5-Dichloro-benzene-1,3-disulfonic acid diamide |
| Diclofenamidum |
| Diclofenamidum [INN-Latin] |
| DSSTox_CID_2922 |
| DSSTox_GSID_22922 |
| DSSTox_RID_76789 |
| DTXSID1022922 |
| EINECS 204-440-6 |
| EX-A1311 |
| FT-0084528 |
| FT-0648264 |
| GJQPMPFPNINLKP-UHFFFAOYSA-N |
| Glafco |
| Glajust |
| Glaucol |
| Glauconide |
| Glaumid |
| GTPL6807 |
| HMS1570B19 |
| HMS2097B19 |
| HMS2236I07 |
| HMS3373G04 |
| HMS3655H06 |
| HSDB 3267 |
| HY-B0397 |
| I14-11391 |
| I7A |
| KS-00001F78 |
| Llorens Brand of Dichlorphenamide |
| LS-30043 |
| m-Benzenedisulfonamide, 4,5-dichloro- |
| MCULE-4570158631 |
| Merck Brand of Dichlorphenamide |
| MLS002154010 |
| MolPort-004-285-635 |
| NCGC00016371-01 |
| NCGC00016371-02 |
| NCGC00016371-04 |
| NCGC00016371-05 |
| OR007978 |
| OR208710 |
| Oratrol |
| Prestwick_1071 |
| Prestwick0_000809 |
| Prestwick1_000809 |
| Prestwick2_000809 |
| Prestwick3_000809 |
| PubChem22279 |
| RW3382 |
| s2177 |
| SBB058142 |
| SCHEMBL112376 |
| SMR001233338 |
| SPBio_002598 |
| SR-01000841825 |
| SR-01000841825-2 |
| ST51014977 |
| sulfonamide 4 |
| Tox21_110401 |
| UNII-VVJ6673MHY |
| VVJ6673MHY |
| W-108466 |
| ZB015115 |
| ZINC896918 |
US Patents and Regulatory Information for KEVEYIS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strongbridge Us | KEVEYIS | dichlorphenamide | TABLET;ORAL | 011366-002 | Aug 7, 2015 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
or, see our see our flat-rate plans
